Procurement Assessment

$130M Pharmaceutical Company


  • The company is a private equity backed manufacturer of pharmaceutical-grade skin care formulations with operations based in Long Island, NY
  • They produce dermatological products that are sold under several commercial brands and private labels at doctor’s offices
  • The company has grown through different acquisitions and is in the process of streamlining operations in anticipation of the owner’s business exit


  • Conducted detailed spend analysis across direct and indirect categories to identify areas of opportunity
  • Conducted several interviews with stakeholders on key processes, policies, and metrics assessing the maturity of the overall procurement function and its strategies
  • Provide a detailed and data-driven assessment report of direct and indirect spend, proposing cost savings opportunities, prioritizing them by ease of implementation versus impact, and identifying “Quick Wins” for immediate impact


  • Identified 24 procedure, policy, and strategic sourcing opportunities across raw materials, transportation, and indirect categories
  • Identified annualized EBITDA impact of $2.8M run rate in increment to those identified by client’s procurement team
  • Proposed working capital benefit of $2.9M through payment term adjustments
  • Provided detailed implementation plan to capture savings in 6 months